{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:52:59Z","timestamp":1773298379781,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.biopha.2021.112145","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T16:07:17Z","timestamp":1631030837000},"page":"112145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Intravitreal lupeol: A new potential therapeutic strategy for noninfectious uveitis"],"prefix":"10.1016","volume":"143","author":[{"given":"Cibele Rodrigues","family":"Toledo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayara Rodrigues Brand\u00e3o","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda Fernanda Moreira","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius Viana","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Pereira de Freitas","family":"Cenachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel V\u00edtor","family":"Vasconcelos-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia Lig\u00f3rio","family":"Fialho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Silva-Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112145_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273940801899822","article-title":"International uveitis study group (iusg): clinical classification of uveitis","volume":"16","author":"Deschenes","year":"2008","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.biopha.2021.112145_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1869-5760-3-32","article-title":"Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE study","volume":"3","author":"Nguyen","year":"2013","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.biopha.2021.112145_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111291","article-title":"Longdan Xiegan Decoction alleviates experimental autoimmune uveitis in rats by inhibiting Notch signaling pathway activation and Th17 cell differentiation","volume":"136","author":"Yin","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.112145_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/jop.2011.0226","article-title":"Tolerability and pharmacokinetics of intravitreal sirolimus","volume":"28","author":"Mudumba","year":"2012","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.112145_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jop.2020.0129","article-title":"Licarin A as a novel drug for inflammatory eye diseases","volume":"37","author":"de Paiva","year":"2021","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.112145_bib6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10787-018-0487-8","article-title":"Propolis modulates NOS2\/arginase-1 pathway in tropomyosin-induced experimental autoimmune uveitis","volume":"26","author":"Touri","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2021.112145_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/a-1377-2596","article-title":"The potential application of pentacyclic triterpenoids in the prevention and treatment of retinal diseases","volume":"87","author":"Cheng","year":"2021","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2021.112145_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105373","article-title":"Lupeol and its derivatives as anticancer and anti-inflammatory agents: molecular mechanisms and therapeutic efficacy","volume":"164","author":"Liu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.112145_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.lfs.2010.11.020","article-title":"Beneficial health effects of lupeol triterpene: a review of preclinical studies","volume":"88","author":"Siddique","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2021.112145_bib10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.biopha.2017.05.093","article-title":"Antiangiogenic activity of PLGA-lupeol implants for potential intravitreal applications","volume":"92","author":"Soares","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.112145_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cbi.2015.12.002","article-title":"Lupeol, a pentacyclic triterpenoid isolated from Vernonia cinerea attenuate selenite induced cataract formation in Sprague Dawley rat pups","volume":"245","author":"Asha","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2021.112145_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11481-015-9623-z","article-title":"Protective effect of lupeol against lipopolysaccharide-induced neuroinflammation via the p38\/c-Jun N-terminal kinase pathway in the adult mouse brain","volume":"11","author":"Badshah","year":"2016","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.biopha.2021.112145_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jff.2017.12.048","article-title":"NF-\u03baB\/twist mediated regulation of colonic inflammation by lupeol in abating dextran sodium sulfate induced colitis in mice","volume":"41","author":"Kasinathan","year":"2018","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.biopha.2021.112145_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.lfs.2016.01.001","article-title":"Lupeol inhibits LPS-induced NF-kappa B signaling in intestinal epithelial cells and macrophages, and attenuates acute and chronic murine colitis","volume":"146","author":"Lee","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2021.112145_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1232816","article-title":"Lupeol counteracts the proinflammatory signalling triggered in macrophages by 7-keto-cholesterol: new perspectives in the therapy of atherosclerosis","volume":"2020","author":"Saha","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2021.112145_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.intimp.2015.11.031","article-title":"The pentacyclic triterpene lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease","volume":"30","author":"Zhu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.112145_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s10633-021-09841-z","article-title":"Anti-angiogenic activity and safety of intraocular application of triterpenes","author":"Toledo","year":"2021","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112145_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1590\/S0102-695X2011005000039","article-title":"Maytenus salicifolia: triterpenes isolated from stems and antioxidant property of extracts from aerial parts","volume":"21","author":"Magalh\u00e3es","year":"2011","journal-title":"Braz. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112145_bib19","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00417-017-3711-0","article-title":"Hypoxia and inflammation in the release of VEGF and interleukins from human retinal pigment epithelial cells","volume":"255","author":"Arjamaa","year":"2017","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112145_bib20","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.molimm.2008.12.001","article-title":"Bacterial endotoxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signaling","volume":"46","author":"Leung","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2021.112145_bib21","series-title":"LEGENDplexTM: Bead-assisted multiplex cytokine profiling by flow cytometry","author":"Lehmann","year":"2019"},{"key":"10.1016\/j.biopha.2021.112145_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106129","article-title":"Intravitreal thalidomide ameliorates inflammation in a model of experimental uveitis induced by BCG","volume":"81","author":"Castro","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.112145_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-017-9621-y","article-title":"ISCEV guide to visual electrodiagnostic procedures","volume":"136","author":"Robson","year":"2018","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112145_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118466","article-title":"Treatment for chemical burning using liquid crystalline nanoparticles as an ophthalmic delivery system for pirfenidone","volume":"568","author":"Silva","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112145_bib25","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1167\/iovs.05-0658","article-title":"TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression","volume":"46","author":"Elner","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2021.112145_bib26","doi-asserted-by":"crossref","first-page":"033","DOI":"10.23937\/2378-346X\/1410033","article-title":"Inflammation and oxidative stress in retinal diseases: the role of intracellular signaling in the retinal pigment epithelium","volume":"2","author":"Mateos","year":"2015","journal-title":"Int. J. Ophthalmol. Clin. Res."},{"key":"10.1016\/j.biopha.2021.112145_bib27","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.3390\/ijms21093037","article-title":"A comprehensive proteomic and phosphoproteomic analysis of retinal pigment epithelium reveals multiple pathway alterations in response to the inflammatory stimuli","volume":"21","author":"Song","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2021.112145_bib28","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1167\/iovs.15-18127","article-title":"Anti-inflammatory effect of dexamethasone controlled released from anterior suprachoroidal polyurethane implants on endotoxin-induced uveitis in rats","volume":"57","author":"Saliba","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2021.112145_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/jop.2018.0092","article-title":"Celastrol ameliorates inflammation in human retinal pigment epithelial cells by suppressing NF-\u03baB signaling","volume":"35","author":"Zhang","year":"2019","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.112145_bib30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3892\/ijmm.2015.2266","article-title":"YCG063 inhibits Pseudomonas aeruginosa LPS-induced inflammation in human retinal pigment epithelial cells through the TLR2-mediated AKT\/NF-\u03baB pathway and ROS-independent pathways","volume":"36","author":"Hwa Paeng","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2021.112145_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12348-019-0189-4","article-title":"Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence","volume":"10","author":"Saincher","year":"2020","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.biopha.2021.112145_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.intimp.2019.02.055","article-title":"Lupeol inhibits LPS-induced neuroinflammation in cerebellar cultures and induces neuroprotection associated to the modulation of astrocyte response and expression of neurotrophic and inflammatory factors","volume":"70","author":"Oliveira-Junior","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.112145_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10633-019-09682-x","article-title":"Corosolic acid: antiangiogenic activity and safety of intravitreal injection in rats eyes","volume":"138","author":"Toledo","year":"2019","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112145_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.taap.2015.10.008","article-title":"Application of electroretinography (ERG) in early drug development for assessing retinal toxicity in rats","volume":"289","author":"Huang","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112145_bib35","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2353\/ajpath.2008.080518","article-title":"Therapeutic effect of melatonin in experimental uveitis","volume":"173","author":"Sande","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2021.112145_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10633-020-09781-0","article-title":"Assessment of the safety of intravitreal injection of metoprolol tartrate in rabbits","volume":"142","author":"Paiva","year":"2021","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112145_bib37","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1089\/jop.2013.0236","article-title":"Pharmacokietics, electrophysiological and morphological effects of the intravitreal injection of mycophenolic acid in rabbits","volume":"30","author":"Gasparin","year":"2014","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.112145_bib38","article-title":"Use of optical coherence tomography and electroretinography to evaluate retinal pathology in a mouse model of autoimmune uveitis","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.112145_bib39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10792-009-9323-x","article-title":"Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunesuppressants: Interventional case series","volume":"30","author":"Neri","year":"2010","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112145_bib40","first-page":"1","article-title":"Systemic immunosuppression is highly effective in the long-term control of inflammatory non-infectious uveitic choroidal neovascularization: a Comparative Study","author":"Neri","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.biopha.2021.112145_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/jop.1992.8.295","article-title":"Effects of steroids and immunosuppressive drugs on endotoxin-uveitis in rabbits","volume":"8","author":"Ohia","year":"1992","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112145_bib42","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1167\/iovs.16-19702","article-title":"Naringenin eye drops inhibit corneal neovascularization by anti-inflammatory and antioxidant mechanisms","volume":"58","author":"Oguido","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2021.112145_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/318621","article-title":"Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis","volume":"2012","author":"Settimio","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2021.112145_bib44","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1211\/0022357011777909","article-title":"New insights into the mechanism of action of the anti-inflammatory triterpene lupeol","volume":"53","author":"Fern\u00e1ndez","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112145_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/671417","article-title":"Macrophages and uveitis in experimental animal models","volume":"2015","author":"M\u00e9rida","year":"2015","journal-title":"Mediat. Inflamm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100929X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100929X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:44:25Z","timestamp":1771919065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100929X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":45,"alternative-id":["S075333222100929X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112145","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal lupeol: A new potential therapeutic strategy for noninfectious uveitis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112145"}}